Catalyst Biosciences Announces Positive Factor IX Clinical Data
Sep 06, 2017 12:01 pm UTC| Business
-- CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy -- SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), today announced positive clinical...
Sep 06, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 06, 2017 -- Sichenzia Ross Ference Kesner LLP (SRFK), a leading corporate securities and full service law firm, is pleased to announce it has relocated its headquarters to the heart of Midtown in New...
South Western Sydney PHN selects Allscripts dbMotion™ Solution to deliver integrated care
Sep 06, 2017 12:01 pm UTC| Business
SYDNEY, Australia, Sept. 06, 2017 -- South Western Sydney PHN (SWSPHN) has selected Allscripts (NASDAQ:MDRX) leading interoperability dbMotion Solution to enable providers to easily transfer and view information between...
Payment Data Systems Acquires Singular Payments, LLC
Sep 06, 2017 12:01 pm UTC| Business
SAN ANTONIO, Sept. 06, 2017 -- Payment Data Systems, Inc. (NASDAQ:PYDS), an integrated electronic payment solutions provider, announced that the acquisition of Singular Payments, LLC was finalized on September 1, 2017....
Sep 06, 2017 12:01 pm UTC| Business
SAN DIEGO, Sept. 06, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced the appointment...
Petrone Worldwide, Inc. Reports 98% Increase in Revenue for Second Quarter
Sep 06, 2017 12:01 pm UTC| Business
Weston, Florida, Sept. 06, 2017 -- Petrone Worldwide, Inc. (OTCQB: PFWI),leader in the hospitality industry with global operations capabilities., announced today its financial results for the second quarter and six...
Ovid Therapeutics Appoints Ana C. Ward as Senior Vice President and General Counsel
Sep 06, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 06, 2017 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced the appointment of Ana C....